Ophthalmology and Hospital, Sher-E-BangIa Nagar, Dhaka-1207 from : January, 2005 to May, 2009. 100 Patient with ocular allergies attending OPD of National Institute of Ophthalmology and Hospital were included. Written informed concent was taken from each patients and a thorough ocular examination was done.
Each of the patient was randomly included in either of the following two groups by simple lottery method;
Group A: 50 Patients receiving olopatadine hydrochloride 0.1% eye drops.
Group B: 50 Patients receiving receiving sodium chromoglycate 2% eye drops.
Patients and evaluators were masked to the supplied drops. Drops were labeled as 'A' and 'B' after removing the commercial sticker. one group receives drug 'A' and the other group receives drug 'B'.
Demographic variables: Age, Sex, Type of allergic conjunctivitis Outcome variables: Itching score, Redness score, Discharge score, Evaluator's scorebaseline and after 21 days of treatment with olopatadine and receiving sodium chromoglycate 2% ophthalmic solution.
Symptom scoring protocol followed Aguilar, 2000 5 . Fig -I shows age distribution of the study subjects. Of the 100 patients Minimum age was 11 years and maximum was 62 years with mean age 27.56 years ± 13.08 (SD). Table -III : shows the distribution of mean redness score of the study subjects. Baseline mean redness score was 2.40 ± 0.39 (SD) in Group A and 2.46 ± 0.54 in Group B. Mean redness score after 07 days was 0.80 ± 0.40 in Group A and 0.90 ± 0.60 in Group B. Mean redness score after 21 days was 0.20 ± 0.31 in Group A and 0.36 ± 0.59 in Group B. Symptom relief was more in Group A cases but the differences was not statistically significant. Similarly the distribution of mean discharge score of the study subjects -Baseline mean discharge score was 2.40 ± 0.69 (SD) in Group A and 2.46 ± 0.70 in Group B. Mean discharge score after 21days was 0.20 ± 0.40 in Group A and 0.30 ± 0.46 in Group B. Symptom relief was more in GroupA cases but the differences was not statistically significant. Redness score of the study shows that mean baseline redness score was 2.40 ± 0.39 (SD) in Group A and 2.46 ± 0.54 in Group B. Mean redness score after 07 days was 0.80 ± 0.40 in Group A and 0.90 ± 0.60 in Group B. Mean redness score after 21 days was 0.20 ± 0.31 in Group A and 0.36 ± 0.59 in Group B. Symptom relief was more in Group A cases but the differences was not statistically significant. Katelaris et al (2002) 8 showed that mean redness score after 15 days was 0.98 in Olopatadine group and 1.15 in sodium cromoglycate group; after 1 month mean redness score was 0.86 in Olopatadine group and 1.03 in sodium cromoglycate group. This result corresponds to that of the current study.
Observation and Results:
Mean discharge score was also found declining after treatment with both the drugs but more in Olopatadine group 9 . But the differences were not statistically significant. 10 showed that global assessment of efficacy was more and quicker in Olopatadine group. James et al (2003) 11 found global assessment efficacy 81% for Olopatadine and 66.3% for Cromolyn. These results correspond to the current study.
In our study the improvement rate was a bit higher as our study was conducted for 21days duration whereas the above mentioned studies were conducted for a period of 7 -14 days.
This study was double masked and randomized clinical study. Patient's feeling regarding symptoms and comfort was taken into account and was assessed by a 4 point scale. Side by side, signs of allergic condition was assessed clinically and compared for the two anti-allergic ophthalmic preparations and marked as either 'satisfactory improvement' or not. For the relieving of symptoms Olopatadine was found to superior over sodium chromoglycate but the difference was not statistically significant. Clinical improvement rate was also higher in Olopatadine group.
Conclusion:
This double masked randomized clinical study done at NIOH concludes that both olopatadine and sodium chromoglycate 2% ophthalmic solutions are almost equally effective in reducing patients' symptoms and signs of allergic conjunctivitis. In a small number of patients olopatadine or sodium chromoglycate 2% alone is not as effective and require additional anti allergic drugs for clinical improvement. Further long-term multicentered study is required for better evaluation.
